Related Experiment Video
Updated: Dec 29, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.7K
Comprehensive Care for Patients with Sarcoidosis
Catharina C Moor1, Vivienne Kahlmann1, Daniel A Culver2
1Department of Respiratory Medicine, Erasmus Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Journal of Clinical Medicine
|February 7, 2020
Summary
Sarcoidosis management requires a comprehensive, multidisciplinary approach. This review summarizes recent knowledge to propose a structured care strategy for improving patient quality of life.
Area of Science:
- Pulmonology and Immunology
- Rheumatology
- Dermatology
Background:
- Sarcoidosis is a multisystem granulomatous disease.
- It is associated with significant morbidity and reduced quality of life.
- Management aims to restore organ function and alleviate symptoms.
Purpose of the Study:
- To review the latest advancements in sarcoidosis care.
- To propose a structured, multidisciplinary approach to sarcoidosis management.
- To enhance patient outcomes and quality of life.
Main Methods:
- Literature review of recent studies on sarcoidosis.
- Synthesis of current pharmacological and supportive treatment strategies.
- Development of a structured management framework.
Main Results:
- Sarcoidosis care necessitates a holistic approach beyond medication.
- Multidisciplinary collaboration is crucial for managing disease heterogeneity.
- Evidence-based supportive measures significantly improve quality of life.
Conclusions:
- A structured, multidisciplinary approach is essential for effective sarcoidosis management.
- Integrating pharmacological and supportive care optimizes patient outcomes.
- This review provides a framework for comprehensive sarcoidosis care.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
669
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
669
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:24Nephrotic Syndrome III : Nursing Management
235
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
235
01:28Acute Coronary Syndrome IV: Interprofessional Care
177
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
177
01:24Cystic Fibrosis: Management
400
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
400
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.9K